CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma
Abstract
See Article, pages 1145–1154 See Article, pages 1145–1154 In this issue of Journal of Hepatology, Diggs et al. have investigated the antitumor activity of a novel immune-based therapeutic strategy in murine models of intrahepatic cholangiocarcinoma (iCCA).[1]Diggs L.P. Ruf B. Ma C. Heinrich B. Cui L. Zhang Q. et al.CD40-mediated immune cell activation enhances response to anti-PD1 in murine intrahepatic cholangiocarcinoma.J Hepatol. 2021; 74:...
Paper Details
Title
CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma
Published Date
May 1, 2021
Journal
Volume
74
Issue
5
Pages
1021 - 1024
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History